Modifies provisions relating to gender transition procedures

HB 1016 bans health care providers from performing gender transition surgeries or prescribing cross-sex hormones and puberty-blocking drugs for gender transition to individuals under 18 years old, with a temporary exception for those already receiving such treatment before August 28, 2023. The bill creates a legal cause of action for affected minors to sue providers for damages, including a presumption of harm if infertility occurs, with a 15-year window to file claims. Exceptions are included for medical conditions like disorders of sex development. Violations by providers can result in license revocation and civil liability.